Year: 2024

The best trade of 2024 was in the making for over two years

3 min read

• Blog
• Finance

The best trade of 2024 was in the making for over two years

Thematics Posted on 9 months ago

If you had $200 million to spare, what would you spend it on? Elon Musk made a...

Read More Read more about The best trade of 2024 was in the making for over two years

Newly-listed NTPC Green Energy shares gain another 5% after adding new capacity

2 min read

• Blog
• Finance

Newly-listed NTPC Green Energy shares gain another 5% after adding new capacity

Thematics Posted on 9 months ago

Recently listed NTPC Green Energy Ltd., the subsidiary of state-run NTPC Ltd., saw shares surge another 5%...

Read More Read more about Newly-listed NTPC Green Energy shares gain another 5% after adding new capacity

Gold prices slip amid strengthening dollar; outlook remains bullish

3 min read

• Blog
• Investment Banking

Gold prices slip amid strengthening dollar; outlook remains bullish

Thematics Posted on 9 months ago

Gold prices experienced a dip on Thursday (November 28), as the US dollar gained strength. Spot gold...

Read More Read more about Gold prices slip amid strengthening dollar; outlook remains bullish

Marketbuzz Podcast With Hormaz Fatakia: Nifty monthly expiry; Fund raising spree continues

1 min read

• Blog
• Investment Banking

Marketbuzz Podcast With Hormaz Fatakia: Nifty monthly expiry; Fund raising spree continues

Thematics Posted on 9 months ago

Hello and Welcome to the Marketbuzz Podcast on CNBC-TV18. Lets bring you up to speed with everything...

Read More Read more about Marketbuzz Podcast With Hormaz Fatakia: Nifty monthly expiry; Fund raising spree continues

Dr. Reddy’s launches India’s only immuno-onco drug for a form of neck and head cancer

2 min read

• Blog
• Finance

Dr. Reddy’s launches India’s only immuno-onco drug for a form of neck and head cancer

Thematics Posted on 9 months ago

Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first...

Read More Read more about Dr. Reddy’s launches India’s only immuno-onco drug for a form of neck and head cancer

CNBC-TV18 Morning Call: Bitcoin tops $96,000, OpenAI gets $1.5 bn from Softbank, Adani Group stocks climb

1 min read

• Blog
• Investment Banking

CNBC-TV18 Morning Call: Bitcoin tops $96,000, OpenAI gets $1.5 bn from Softbank, Adani Group stocks climb

Thematics Posted on 9 months ago

S&P 500 closes lower ahead of Thanksgiving holiday: selloff in giant technology companies dragged down stocks, while...

Read More Read more about CNBC-TV18 Morning Call: Bitcoin tops $96,000, OpenAI gets $1.5 bn from Softbank, Adani Group stocks climb

IREDA shares gain up to 8.5% as PSU stock rebounds for the fifth day in a row

2 min read

• Blog
• Investment Banking

IREDA shares gain up to 8.5% as PSU stock rebounds for the fifth day in a row

Thematics Posted on 9 months ago

Shares of Indian Renewable Energy Development Agency (IREDA) Ltd. gained as much as 8.5% on Thursday, November...

Read More Read more about IREDA shares gain up to 8.5% as PSU stock rebounds for the fifth day in a row

Marico will navigate the current tough environment, says Goldman Sachs with ₹720 target

2 min read

• Blog
• Investment Banking

Marico will navigate the current tough environment, says Goldman Sachs with ₹720 target

Thematics Posted on 9 months ago

Global brokerage firm Goldman Sachs maintains a ‘Buy’ rating on Marico, with a target price of ₹720...

Read More Read more about Marico will navigate the current tough environment, says Goldman Sachs with ₹720 target

Amber Enterprises shares’ 107% returns in 2024 prompts a Goldman Sachs downgrade

2 min read

• Blog
• Investment Banking

Amber Enterprises shares’ 107% returns in 2024 prompts a Goldman Sachs downgrade

Thematics Posted on 9 months ago

Brokerage firm Goldman Sachs has downgraded shares of Amber Enterprises to "neutral" from its earlier rating of...

Read More Read more about Amber Enterprises shares’ 107% returns in 2024 prompts a Goldman Sachs downgrade

HSBC sees EV drive challenges, says India to remain multi-powertrain till 5-10 years

3 min read

• Blog
• Finance

HSBC sees EV drive challenges, says India to remain multi-powertrain till 5-10 years

Thematics Posted on 9 months ago

Indian automakers are strategising their EV plans for the coming years, with frequent launches across segments, whether...

Read More Read more about HSBC sees EV drive challenges, says India to remain multi-powertrain till 5-10 years